Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kestler, D.
Right arrow Articles by Hall, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kestler, D.
Right arrow Articles by Hall, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Detection and analysis of an alternatively spliced isoform of interleukin-6 mRNA in peripheral blood mononuclear cells

DP Kestler, S Agarwal, J Cobb, KM Goldstein and RE Hall

Department of Medicine, University of Tennessee Medical Center at Knoxville 37920, USA.

Oligonucleotide primers for human interleukin-6 (IL-6) that bracketed the entire coding region of the gene were used in reverse transciptase- polymerase chain reaction (RT-PCR) studies to examine lL-6 expression in peripheral blood mononuclear cells (PBMC). In addition to the predicted 0.64-kb RT-PCR product, a second 0.45-kb product was observed. Cloning and dideoxy sequence analysis of this product revealed evidence for an alternatively spliced lL-6 transcript lacking exon II. Further RT-PCR analysis using forward primers ending at or one base before the exon I donor splice site again yielded both products. Additional primers were designed and successfully used to selectively distinguish the two forms of IL-6 transcript. Both transcripts were prominent in peripheral blood monocytes and lymphocytes, whereas only the 0.64-kb, full-length transcript was prominent in the lL-6-producing 5637 (human bladder carcinoma) cell line. Northern analysis revealed, in addition to the predominant 1.3-kb transcript, several minor transcripts at 1.9 to 4.8 kb that hybridized with the alternatively spliced cDNA probe but not with an exon II probe. Western analysis revealed lL-6 polypeptides of predicted size (26 to 29 kD) in culture medium from PBMC, while showing an immunoreactive band at 17 kD in cell lysates. These findings suggest the existence of an alternatively spliced form of lL-6 mRNA, which would encode for a polypeptide missing the gp130 interactive (signal-transducing) domain contained in exon II while retaining the lL-6 receptor (p80) domain. Such a molecule could in theory function as a natural antagonist of lL-6, as it would be expected to bind to the IL-6 receptor but not lead to signal transduction.

Volume 86, Issue 12, pp. 4559-4567, 12/15/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R.-M. Pelletier, S. R. Yoon, C. D. Akpovi, E. Silvas, and M. L. Vitale
Defects in the regulatory clearance mechanisms favor the breakdown of self-tolerance during spontaneous autoimmune orchitis
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R743 - R762.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Yuan, R. Wang, Y. Lee, C. Y. Chen, X. Yu, Z. Wu, D. Huang, L. Shen, and Z. W. Chen
Tuberculosis-Induced Variant IL-4 mRNA Encodes a Cytokine Functioning As Growth Factor for (E)-4-Hydroxy-3-Methyl-But-2-Enyl Pyrophosphate-Specific V{gamma}2V{delta}2 T Cells
J. Immunol., January 15, 2009; 182(2): 811 - 819.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Alberti, T. Bachelot, A. Duc, C. Biota, and J. Y. Blay
A Spliced Isoform of Interleukin 6 mRNA Produced by Renal Cell Carcinoma Encodes for an Interleukin 6 Inhibitor
Cancer Res., January 1, 2005; 65(1): 2 - 5.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. K. Geiss, M. C. An, R. E. Bumgarner, E. Hammersmark, D. Cunningham, and M. G. Katze
Global Impact of Influenza Virus on Cellular Pathways Is Mediated by both Replication-Dependent and -Independent Events
J. Virol., May 1, 2001; 75(9): 4321 - 4331.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
B. P. Haines, R. B. Voyle, and P. D. Rathjen
Intracellular and Extracellular Leukemia Inhibitory Factor Proteins Have Different Cellular Activities That Are Mediated by Distinct Protein Motifs
Mol. Biol. Cell, April 1, 2000; 11(4): 1369 - 1383.
[Abstract] [Full Text]


Home page
CVIHome page
S. P. Atamas and B. White
Interleukin 4 in Systemic Sclerosis: Not Just an Increase
Clin. Vaccine Immunol., September 1, 1999; 6(5): 658 - 659.
[Full Text] [PDF]


Home page
J. Immunol.Home page
B. P. Haines, R. B. Voyle, T. A. Pelton, R. Forrest, and P. D. Rathjen
Complex Conserved Organization of the Mammalian Leukemia Inhibitory Factor Gene: Regulated Expression of Intracellular and Extracellular Cytokines
J. Immunol., April 15, 1999; 162(8): 4637 - 4646.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020